severe asthma

The impact of anti-IgE treatment on the airway microbiome in asthma
Ashley Sullivan, Chris Ward, Deborah Casey, Deirdre Flynn, Eoin B. Hunt, Joseph A. Eustace, Paul M. O' Byrne, Barry J. Plant, John A. Macsharry, Desmond M. Murphy

European Respiratory Journal Sep 2020, 56 (suppl 64) 5284; DOI: 10.1183/13993003.congress-2020.5284
CD6-ALCAM Pathway is Elevated in Patients with Severe Asthma
Manali Mukherjee, Nan Zhao, Katherine Radford, Sole Gatto, Adam Pavlicek, Jeanette Ampudia, Cherie Ng, Stephen Connelly, Param Nair

European Respiratory Journal Sep 2020, 56 (suppl 64) 5283; DOI: 10.1183/13993003.congress-2020.5283
Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma
Maisha Jabeen, Teresa Street, Dona Foster, Derrick Crook, Nicholas Sanderson, Ian Pavord, Paul Klenerman, Timothy Stopford Christopher Hinks

European Respiratory Journal Sep 2020, 56 (suppl 64) 4930; DOI: 10.1183/13993003.congress-2020.4930
Longitudinal characteristics of the Severe Asthma Research Program (SARP) clinical clusters
Xingnan Li, Wendy Moore, Huashi Li, William Busse, Mario Castro, Serpil Erzurum, John Fahy, Benjamin Gaston, Elliot Israel, Nizar Jarjour, Bruce Levy, Sally Wenzel, Deborah Meyers, Eugene Bleecker

European Respiratory Journal Sep 2020, 56 (suppl 64) 5038; DOI: 10.1183/13993003.congress-2020.5038
Plasma protein profiles as markers of asthma severity and exposure to oral corticosteroids in U-BIOPRED and BIOAIR
Maria Mikus, Johan Kolmert, Anna James, Lars I Andersson, Jörgen Östling, Cristina Gomez, Richard Knowles, Barbro Dahlén, Ratko Djukanovic, Ian M Adcock, Peter Nilsson, Sven-Erik Dahlén

European Respiratory Journal Sep 2020, 56 (suppl 64) 5278; DOI: 10.1183/13993003.congress-2020.5278
Cost-effectiveness of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
Emanuela Resta, Giovanna Elisiana Carpagnano, Corrado Pelaia, Maria D'Amato, Nunzio Crimi, Nicola Scichilone, Cecilia Calabrese, Onofrio Resta, Giulia Scioscia, Girolamo Pelaia, Maria Pia Foschino Barbaro

European Respiratory Journal Sep 2020, 56 (suppl 64) 4809; DOI: 10.1183/13993003.congress-2020.4809
Continued long-term mepolizumab in severe eosinophilic asthma protects from asthma worsening versus stopping mepolizumab: COMET trial
Elisabeth H.D. Bel, Wendy C Moore, Oliver Kornmann, Claude Poirier, Nirihiro Kaneko, Steven G Smith, Neil Martin, Martyn J Gilson, Robert G Price, Eric S Bradford, Marc Humbert

European Respiratory Journal Sep 2020, 56 (suppl 64) 5280; DOI: 10.1183/13993003.congress-2020.5280
Risk factors for severe asthma among adults with asthma
Helena Backman, Caroline Stridsman, Sven-Arne Jansson, Linnea Hedman, Hannu Kankaanranta, Anne Lindberg, Bo Lundback, Eva Rönmark

European Respiratory Journal Sep 2020, 56 (suppl 64) 4642; DOI: 10.1183/13993003.congress-2020.4642
Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population
Jieqiong Yang, John Busby, Liam G Heaney, Paul E Pfeffer, David J Jackson, Adel H Mansur, Andrew Menzies-Gow, Salman Siddiqui, Christopher E Brightling, Rob Niven, Mitesh Patel, Neil C Thomson, Rekha Chaudhuri

European Respiratory Journal Sep 2020, 56 (suppl 64) 5039; DOI: 10.1183/13993003.congress-2020.5039
Anti-IL-5 therapy and the airway microbiome in asthma
Ashley Sullivan, Chris Ward, Deborah Casey, Deirdre Flynn, Eoin B. Hunt, Joseph A. Eustace, Paul M. O' Byrne, Barry J. Plant, John A. Macsharry, Desmond M. Murphy

European Respiratory Journal Sep 2020, 56 (suppl 64) 5279; DOI: 10.1183/13993003.congress-2020.5279

Main menu

User menu

Search

severe asthma

Pages

Contact us